• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2025 - 2030年澳大利亚针对性国家肺癌筛查计划的 eligible population估计数。(这里“eligible population”可能有更准确的医学术语对应,但仅从字面看是“符合条件的人群”)

Estimates of the eligible population for Australia's targeted National Lung Cancer Screening Program, 2025-2030.

作者信息

Wade Stephen, Ngo Preston, He Yue, Caruana Michael, Steinberg Julia, Luo Qingwei, David Michael, McWilliams Annette, Fong Kwun M, Canfell Karen, Weber Marianne F

机构信息

The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Woolloomooloo, NSW, Australia.

The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Woolloomooloo, NSW, Australia; School of Medicine and Dentistry, Griffith University, Gold Coast, QLD, Australia.

出版信息

Public Health Res Pract. 2024 Dec 18. doi: 10.17061/phrp34342410.

DOI:10.17061/phrp34342410
PMID:39694854
Abstract

Australia's National Lung Cancer Screening Program will commence in July 2025, targeted at individuals aged 50-70 years with a 30 pack-year smoking history (equivalent to 20 cigarettes per day for 30 years), who either currently smoke or have quit within the past 10 years. We forecasted the number of screening-eligible individuals over the first 5 years of the program using data from the 2019 National Drug Strategy Household Survey and the 2022 Australian Bureau of Statistics population projections. Multiple imputation integrated with predictive modelling of future or unmeasured smoking characteristics was used to address missing data and, simultaneously, to project individuals' smoking histories to 2030. In 2025, 930 500 (95% prediction interval 852 200-1 019 000) individuals were estimated to be eligible, with the number meeting the criteria declining slightly during the years 2025-2030 in all Australian jurisdictions. Overall, 26-30% of those eligible will have quit smoking, and 70-74% will currently smoke. These estimates can be used in resource planning and as an indicative denominator to track participation rates for the program over time.

摘要

澳大利亚国家肺癌筛查计划将于2025年7月启动,目标人群为年龄在50至70岁之间、有30包年吸烟史(相当于每天吸20支烟,持续30年)的个人,这些人目前仍在吸烟或在过去10年内戒烟。我们利用2019年国家毒品战略家庭调查的数据和2022年澳大利亚统计局的人口预测,预测了该计划前5年符合筛查条件的人数。采用多重填补法并结合对未来或未测量吸烟特征的预测模型来处理缺失数据,同时将个人吸烟史预测到2030年。预计到2025年,符合条件的人数为930500人(95%预测区间为852200 - 1019000人),在2025 - 2030年期间,澳大利亚所有司法管辖区内符合标准的人数略有下降。总体而言,符合条件的人群中,26% - 30%已经戒烟,70% - 74%目前仍在吸烟。这些估计数可用于资源规划,并作为一个指示性分母来跟踪该计划随时间推移的参与率。

相似文献

1
Estimates of the eligible population for Australia's targeted National Lung Cancer Screening Program, 2025-2030.2025 - 2030年澳大利亚针对性国家肺癌筛查计划的 eligible population估计数。(这里“eligible population”可能有更准确的医学术语对应,但仅从字面看是“符合条件的人群”)
Public Health Res Pract. 2024 Dec 18. doi: 10.17061/phrp34342410.
2
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.肺癌低剂量计算机断层扫描筛查的获益与危害评估:美国预防服务工作组的建模研究。
JAMA. 2021 Mar 9;325(10):988-997. doi: 10.1001/jama.2021.1077.
3
Effect of vaping on past-year smoking cessation success of Australians in 2019-evidence from a national survey.2019 年澳大利亚吸电子烟者过去一年戒烟成功率的影响——来自全国调查的证据。
Addiction. 2022 Aug;117(8):2306-2315. doi: 10.1111/add.15897. Epub 2022 Apr 25.
4
Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.不符合肺癌筛查条件的长期吸烟者的烟草使用情况及戒烟动机。
Lung Cancer. 2017 Sep;111:101-107. doi: 10.1016/j.lungcan.2017.07.017. Epub 2017 Jul 19.
5
The impact of COVID-19 on participation in Australia's National Bowel Cancer Screening Program by people with severe mental illness: A national data linkage study.2019年冠状病毒病对澳大利亚严重精神疾病患者参与国家肠癌筛查项目的影响:一项全国数据关联研究。
Aust N Z J Psychiatry. 2025 Jul;59(7):640-650. doi: 10.1177/00048674251336034. Epub 2025 Apr 28.
6
Integrating Smoking Cessation Into Low-Dose Computed Tomography Lung Cancer Screening: Results of the Ontario, Canada Pilot.将戒烟纳入低剂量计算机断层扫描肺癌筛查:加拿大安大略省试点项目的结果
J Thorac Oncol. 2023 Oct;18(10):1323-1333. doi: 10.1016/j.jtho.2023.07.004. Epub 2023 Jul 6.
7
Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria.美国肺癌筛查 eligible 人群的特征及简化标准对 eligibility 的预测
Transl Cancer Res. 2024 May 31;13(5):2155-2163. doi: 10.21037/tcr-23-1942. Epub 2024 May 20.
8
Prevalence of cigarette and e-cigarette use among U.S. adults eligible for lung cancer screening based on updated USPSTF guidelines.根据美国预防服务工作组(USPSTF)最新指南,符合肺癌筛查条件的美国成年人中香烟和电子烟的使用情况。
Cancer Epidemiol. 2022 Feb;76:102079. doi: 10.1016/j.canep.2021.102079. Epub 2021 Dec 8.
9
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.肺癌筛查:美国预防服务工作组推荐声明。
JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117.
10
Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare.医疗保险中实施低剂量计算机断层扫描肺癌筛查的预计临床、资源使用及财政影响
J Oncol Pract. 2015 Jul;11(4):267-72. doi: 10.1200/JOP.2014.002600. Epub 2015 May 5.

引用本文的文献

1
A Health Economic Evaluation of Routine Hepatocellular Carcinoma Surveillance for People with Compensated Cirrhosis to Support Australian Clinical Guidelines.对代偿期肝硬化患者进行常规肝细胞癌监测的卫生经济学评估,以支持澳大利亚临床指南
MDM Policy Pract. 2025 Jun 26;10(1):23814683251344962. doi: 10.1177/23814683251344962. eCollection 2025 Jan-Jun.
2
'Every Touch Point Is an Opportunity': Tobacco Control Experts' Views on How to Implement Smoking Cessation Interventions Within an Australian Lung Cancer Screening Program.“每个接触点都是一个机会”:控烟专家对如何在澳大利亚肺癌筛查项目中实施戒烟干预措施的看法。
Cancer Med. 2025 May;14(10):e70963. doi: 10.1002/cam4.70963.